About IBJ

  • What is IBJ?

    Iberoamerican Journals (IBJ) is an academic publishing project, nonprofit and open access. Which objectives are hosting all kinds of quality biomedical research and facilitating the process of publishing authors from around the world and especially in the Latin American region.

  • Who makes IBJ?

    IBJ is driven by a group of professionals and academics linked to the Universidad Autonoma of Madrid with many years of experience in both basic and clinical biomedical research. The reviewers and editors that collaborate with IBJ are academics and professionals from Spain and Latin America.

  • Why was IBJ created?

    IBJ was created with the view to facilitating scientific and clinic communication in Latin America and permitting easy access internationally.

  • Why publish in IBJ?

    Multilingual: Spanish, Portuguese, English. Authors can decide which language prefer to carry their scientific communication.

    Quality Review, transparent and reasoned: We provide convenient publishing without lowering the scientific publication requirements. The peer review is carry out in the same linguistic and scientific scope through a reasoned critique with the possibility of claims to the editor in charge which minimizes the peer-review regulation risk.

    Pre-publishing support: We provide pre-publishing support for authors upon request or when the publisher deems it necessary. Pre-publisher support at cost price and full transparency
    (see publication cost).

  • Which journals do we publish?

    Currently IBJ publishes three differentiated journals:

    IBJ Plus
    (Spanish/Portuguese/English). Biomedicine.

    IBJ Clinical Pharmacology
    Spanish/Portuguese/English). Clinical Pharmacology.

    IBJ Infectious Diseases
    (Spanish/Portuguese/English). Infectious Diseases.

  • Mission

    Facilitate communication of the Latin American scientific community, both regionally and internationally.

  • Vision

    Become the cutting edge biomedical research magazine in the Latin American region.

  • Main objective

    Channel and promote the scientific production in the biomedical area in the Latin American Region.

  • Objectives towards the investigator

    Scope: Provide a more extensive dissemination of your research, both regionally and internationally. Our Open Access service allows free access to content. Indexation to Google, PubMed, Scopus, etc.

    Impact: Provide visibility indicators with every publication, either through a higher number of visits and downloads in Latin America and internationally, or through citations in SCI, Cite, Scimago etc. In order to make this, an important media exposure campaign will be promoted.

    Professionalism: Providing the highest ethical standards in research, publishing and scientific report. Each of the articles are extensively reviewed by professional academics and experienced editors.


IBJ is comprised of three lines of Journals

IBJ Plus


IBJ Plus publishes original articles in all fields of biomedicine, from the most basic to the most applied disciplines. IBJ Plus is especially interested in publishing articles from the most undervalue disciplines in current publications, in the studies of translational research, cross-sectional studies and in national and international collaborative efforts.


Infectious Diseases

Infectious Diseases

IBJ Infectious Diseases publishes original articles, reviews, case reports, therapeutic protocols and recommendations in the area of infectious diseases, including all kinds of bacterial, viral and fungal infections and emerging infectious and tropical. Especially interested in cross-sectional studies and in national and international collaborative efforts.


IBJ Clinical Pharmacology

Clinical Pharmacology

IBJ Clinical Pharmacology publishes original articles, reviews, case reports, etc., in the area of Clinical Pharmacology, including pharmacokinetics, pharmacodynamics, pharmacometrics, therapeutic drug monitoring, toxicology, pharmacogenetics, drug, cell and gene therapy, pharmacoepidemiology, study of drug use, pharmacoeconomics, drug regulation. Especially interested in cross-sectional studies and in national and international collaborative efforts.



Author? reviewer? find out about all our procedures and guidelines.


The publication process


The peer review

Other policies and guidelines

About Open Access and OJS

Contact us

Fill in the following form and we will reply as brief as possible.


* indicates required